(Q54120809)

25 May 2018

review article

1 reference

title

Resistance issues and treatment implications: pneumococcus, Staphylococcus aureus, and gram-negative rods. (English)

1 reference

25 May 2018

main subject

Staphylococcus aureus

1 reference

D E Low

1

1 reference

25 May 2018

publication date

1 September 1998

1 reference

25 May 2018

Infectious Disease Clinics of North America

published in

1 reference

25 May 2018

volume

12

1 reference

25 May 2018

issue

3

1 reference

25 May 2018

page(s)

613-30, viii

1 reference

25 May 2018

Mutations in the dihydrofolate reductase gene of trimethoprim-resistant isolates of Streptococcus pneumoniae

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Emerging resistance to antimicrobial agents in gram-positive bacteria. Pneumococci.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

New prospects for antibacterial agents against multidrug-resistant pneumococci

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

World-wide development of antibiotic resistance in pneumococci

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Increase in bacteraemic pneumococcal infections in children

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Patterns of methicillin-resistant Staphylococcus aureus prevalence

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Methicillin-resistant Staphylococcus aureus (MRSA): a briefing for acute care hospitals and nursing facilities. The AHA Technical Panel on Infections Within Hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing beta-lactamases in a single isolate

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Penicillin dosing for pneumococcal pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Nomenclature of TEM beta-lactamases.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

A functional classification scheme for beta-lactamases and its correlation with molecular structure

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Low-level methicillin resistance in strains of Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Novel extended-spectrum TEM-type beta-lactamase from an Escherichia coli isolate resistant to ceftazidime and susceptible to cephalothin.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrug-resistant Streptococcus pneumoniae: a multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Horizontal transfer of multiple penicillin-binding protein genes, and capsular biosynthetic genes, in natural populations of Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Occurrence and detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae at a veterans medical center: seek and you may find

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Transposable multiple antibiotic resistance in Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Multiplicity of macrolide-lincosamide-streptogramin antibiotic resistance determinants

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Antimicrobial resistance issues of the future

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Origin and molecular epidemiology of penicillin-binding-protein-mediated resistance to beta-lactam antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

TEM- and SHV-derived extended-spectrum beta-lactamases: relationship between selection, structure and function

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Multiple mechanisms of erythromycin resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Distribution of genes encoding erythromycin ribosomal methylases and an erythromycin efflux pump in epidemiologically distinct groups of staphylococci.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

An overview of nosocomial infections, including the role of the microbiology laboratory

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Analysis of gyrA and grlA mutations in stepwise-selected ciprofloxacin-resistant mutants of Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

A prediction rule to identify low-risk patients with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Study of the comparative activity of piperacillin/tazobactam with currently available antibiotics against 8206 aerobic isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and beta-lactam-beta-lactamase inhibitor combinations by hyperproduction of SHV-5 beta-lactamase.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Management of infections caused by antibiotic-resistant Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

THE SPECIFIC POLYSACCHARIDE CONTENT OF PNEUMONIC LUNGS.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Increase in pneumococcal bacteraemia in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for outpatients with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Choice of an oral beta-lactam antibiotic for infections due to penicillin-resistant Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

30 years of penicillin-resistant S pneumoniae: myth or reality?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Use of a ribosomal RNA gene probe for the epidemiological study of methicillin and ciprofloxacin resistant Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Susceptibility of ciprofloxacin-resistant staphylococci and enterococci to clinafloxacin.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Molecular characterization of nine different types of mutants among 107 inhibitor-resistant TEM beta-lactamases from clinical isolates of Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Penicillin-resistant Streptococcus pneumoniae in the Netherlands: results of a 1-year molecular epidemiologic survey

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram-positive and gram-negative pathogens from respiratory tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Emergence of Multiply Resistant Pneumococci

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Antimicrobial-resistant pathogens in the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Inducible NorA-mediated multidrug resistance in Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Epidemiology, control and treatment of multiresistant pneumococci

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Intrinsic and unusual resistance to macrolide, lincosamide, and streptogramin antibiotics in bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

beta-Lactamases in laboratory and clinical resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Quinupristin/dalfopristin: spectrum of activity, pharmacokinetics, and initial clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Community-acquired pneumonia requiring hospitalization: 5-year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Implications of acquired oxacillin resistance in the management and control of Staphylococcus aureus infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Comparative in vitro activities of several new fluoroquinolones and beta-lactam antimicrobial agents against community isolates of Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Further characterization of borderline methicillin-resistant Staphylococcus aureus and analysis of penicillin-binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Infections caused by erythromycin-resistant Streptococcus pneumoniae: incidence, risk factors, and response to therapy in a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Genetics of resistance to third-generation cephalosporins in clinical isolates of Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Characterization of vancomycin resistance in Enterococcus faecium and Enterococcus faecalis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

In vivo selection of a cephamycin-resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 beta-lactamase.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Comparative activity of ampicillin, amoxycillin, amoxycillin/clavulanate and cefotaxime against 189 penicillin-susceptible and -resistant pneumococci.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Activity of ampicillin-sulbactam and oxacillin in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

New quinolones and gram-positive bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Invasive pneumococcal infections. A comparison between adults and children

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Efficacy of different beta-lactams against an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain in the rat intra-abdominal abscess model

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Rapid geographic spread of a methicillin-resistant Staphylococcus aureus strain

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Characterisation and molecular cloning of the novel macrolide-streptogramin B resistance determinant from Staphylococcus epidermidis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Emergence of vancomycin resistance in coagulase-negative staphylococci

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Canadian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae. Canadian Bacterial Surveillance Network

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

A complex mutant of TEM-1 beta-lactamase with mutations encountered in both IRT-4 and extended-spectrum TEM-15, produced by an Escherichia coli clinical isolate.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. The Pneumococcal Surveillance Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Antibiotic resistance: counting the cost

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Therapy for penicillin-resistant Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Contribution of mutations in gyrA and parC genes to fluoroquinolone resistance of mutants of Streptococcus pneumoniae obtained in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Bacteremic nosocomial pneumonia. A 7-year experience in one institution.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. The Laboratory Investigator Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Emerging resistance to fluoroquinolones in staphylococci: an alert

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Antibiotic-resistant Streptococcus pneumoniae: clinical and epidemiologic aspects.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Erythromycin resistance by ribosome modification

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Prevalence of erm gene classes in erythromycin-resistant Staphylococcus aureus strains isolated between 1959 and 1988.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Streptococcus pneumoniae resistance to fluoroquinolones

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Effect of hyperproduction of TEM-1 beta-lactamase on in vitro susceptibility of Escherichia coli to beta-lactam antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Active efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 beta-lactamase conferring resistance to beta-lactamase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970201-4

7 January 2021

10.1016/S0891-5520(05)70201-4

Identifiers

DOI

1 reference

25 May 2018

release_vn4h3saembdv5eqf2rpmbfdo3y

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vn4h3saembdv5eqf2rpmbfdo3y

24 November 2022

mapped directly with Wikidata item

1 reference

25 May 2018